NFKB1 and Miyoshi myopathy: Nevertheless, the exact mechanism of how SCFAs affect MM deserves further investigation, and it is possible that increasing the abundance of SCFAs-producing gut microbiota could inhibit the secretion of inflammatory factors and activation of NF-κB signaling pathways to control inflammation and further slow the progression of MM.